Sunday, 6 December 2020

Protagonist Announces Updated Phase 2 Data Presented at ASH Annual Meeting Supporting Long Term Efficacy of Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera - Yahoo Finance

Protagonist Announces Updated Phase 2 Data Presented at ASH Annual Meeting Supporting Long Term Efficacy of Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera  Yahoo Finance

from "phlebotomist" - Google News https://yhoo.it/39LQRGX

No comments:

Post a Comment